Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol effects on reward system in perimenopausal depression
NCT02255175Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2015
- Primary completion
- Oct 2018
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, open-label trial of estradiol in perimenopausal depression (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Caudate Signal Intensity in Response to Reward During the MID fMRI Task, Nucleus Accumbens (NAcc) Signal Intensity in Response to Reward During the MID fMRI Task and 1 more. Started Oct 2015; status: completed.
02
Drugs
estradiol
03
Conditions
perimenopausal depression
Beyond the preview
Go deeper on NCT02255175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255175.